Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
RG6035
/
Roche
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
RG6035
/
Roche
New P1 trial:
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous RO7121932 in Participants With Multiple Sclerosis.
(clinicaltrials.gov) - Jan 30, 2023
P1
, N=63, Recruiting,
Sponsor: Hoffmann-La Roche